News

MONTCO Today on MSN16h
GSK Bets Big on ‘Game-Changing’ Liver Disease Drug
GSK has announced a $1.2 billion deal to acquire efimosfermin alfa from Boston Pharmaceuticals, writes John George for the ...
Zacks Investment Research on MSN10h
Pharma Stock Roundup: BAYRY Q1 Earnings, NVO & GSK's New Deals
Bayer BAYRY announced first-quarter 2025 results. Novo Nordisk NVO and GSK plc GSK announced licensing deals with smaller ...